PT Kalbe Farma Tbk (FRA:LCLA) Tariff Resilience Score: 6/10 (As of Jul. 05, 2026)


FRA:LCLA PT Kalbe Farma Tbk FRA:LCLA
76 GF Score
Price €0.03
GF Value €0.07
Valuation Significantly Undervalued
! 2 Warning Signs
View Full Analysis

What is PT Kalbe Farma Tbk Tariff Resilience Score?

PT Kalbe Farma Tbk FRA:LCLA 76 Tariff Resilience Score is 6 as of Jul. 05, 2026. GuruFocus rates FRA:LCLA with a GF Score™ of 76/100 and a GF Value™ of €0.07 (Significantly Undervalued). The stock has 2 warning signs investors should review. Among 1,028 Drug Manufacturers companies, PT Kalbe Farma Tbk ranks better than 91.05% on this metric.

PT Kalbe Farma Tbk has the Tariff Resilience Score of 6, which implies that the company might have Average Resilient.

PT Kalbe Farma Tbk has PTKFF has moderate tariff exposure due to its pharmaceutical imports and exports. While it benefits from some industry-specific exemptions, changes can affect costs. The company can mitigate risks through alternative suppliers and strategic pricing.

Tariff Resilience Score is a ranking system developed by GuruFocus to measure a company's exposure to international trade tariffs, rated on a scale from 0 to 10. It takes into account key factors such as global supply chain dependencies, manufacturing locations versus sales markets, import / export balance and percentage of revenue, and more.

The company's exposure to international trade tariffs based on these criteria:

1. Global supply chain dependencies
2. Manufacturing locations versus sales markets
3. Import/export balance and percentage of revenue
4. Historical impact from previous tariff changes
5. Available mitigation strategies (alternative suppliers, pricing power)
6. Industry-specific tariff exemptions or vulnerabilities

Based on the research, GuruFocus believes PT Kalbe Farma Tbk might have Average Resilient.

PT Kalbe Farma Tbk  (FRA:LCLA) Tariff Resilience Score Explanation

The Tariff Resilience Score ranges from 0 to 10, with 10 as the most resilient. GuruFocus divided Moat Score into following 3 categories:

Tariff Resilience Score Resilience Level
7 - 10Highly Resilient
4 - 6Average Resilient
0 - 3Highly Vulnerable

PT Kalbe Farma Tbk Tariff Resilience Score Related Terms

FRA:LCLA vs LLY, JNJ, ABBV: Tariff Resilience Score Comparison

For the Drug Manufacturers - General subindustry, PT Kalbe Farma Tbk's Tariff Resilience Score, along with its competitors' market caps and Tariff Resilience Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

PT Kalbe Farma Tbk Tariff Resilience Score vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, PT Kalbe Farma Tbk's Tariff Resilience Score distribution charts can be found below:

* The bar in red indicates where PT Kalbe Farma Tbk's Tariff Resilience Score falls into.


FRA:LCLA
76GF Score
PT Kalbe Farma Tbk FRA:LCLA
Tariff Resilience Score is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis
What does a Tariff Resilience Score of 6 mean?
PT Kalbe Farma Tbk (FRA:LCLA) has a Tariff Resilience Score of 6 as of Jul. 05, 2026. Tariff Score is a ranking system developed by GuruFocus to measure a company's exposure to international trade tariffs, rated on a scale from 0 to 10. It takes into account key factors such as global supply chain dependencies, manufacturing locations versus sales markets, import / export balance and percentage of revenue, and more. According to the industry distribution chart, PT Kalbe Farma Tbk ranks #92 out of 1028 companies in the Drug Manufacturers industry, placing it in the top 8.9%.
Is PT Kalbe Farma Tbk's Tariff Resilience Score too high?
PT Kalbe Farma Tbk's current Tariff Resilience Score is 6. Based on the distribution chart, PT Kalbe Farma Tbk ranks #92 out of 1028 companies in the Drug Manufacturers industry, which is in the top quartile — a strong position relative to peers. Overall, PT Kalbe Farma Tbk has a GF Score™ of 76/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does PT Kalbe Farma Tbk's Tariff Resilience Score compare to LLY and JNJ?
According to the Drug Manufacturers industry distribution chart, PT Kalbe Farma Tbk ranks #92 out of 1028 companies for Tariff Resilience Score. This places PT Kalbe Farma Tbk in the top 9% of its industry — outperforming the majority of peers. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Tariff Resilience Score for a Drug Manufacturers company?
A good Tariff Resilience Score depends on the Drug Manufacturers industry context. However, Tariff Resilience Score should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Tariff Resilience Score mean?
A high Tariff Resilience Score can signal that a stock is expensive relative to its fundamentals. Tariff Score is a ranking system developed by GuruFocus to measure a company's exposure to international trade tariffs, rated on a scale from 0 to 10. It takes into account key factors such as global supply chain dependencies, manufacturing locations versus sales markets, import / export balance and percentage of revenue, and more. PT Kalbe Farma Tbk's current Tariff Resilience Score is 6. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is PT Kalbe Farma Tbk stock overvalued right now?
Based on GuruFocus' analysis, PT Kalbe Farma Tbk (FRA:LCLA) is currently considered Significantly Undervalued. The stock's GF Value™ is €0.07, compared to a current price of €0.03 — trading 58.6% below its estimated fair value. The current Tariff Resilience Score is 6. PT Kalbe Farma Tbk's overall GF Score™ is 76/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Tariff Resilience Score calculated?
Tariff Resilience Score is calculated from a company's financial statements. For PT Kalbe Farma Tbk (FRA:LCLA), the current Tariff Resilience Score is 6 as of Jul. 05, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is PT Kalbe Farma Tbk (FRA:LCLA) Overvalued in 2026?

Based on GuruFocus' analysis, PT Kalbe Farma Tbk stock appears to be undervalued. The current stock price of €0.03 is trading 58.6% below its estimated GF Value™ of €0.07. GuruFocus considers PT Kalbe Farma Tbk to be Significantly Undervalued.

Key valuation signals for FRA:LCLA:

  • Tariff Resilience Score: 6
  • GF Value™: €0.07 vs. price of €0.03 (58.6% below fair value)
  • GF Score™: 76/100 with 2 warning signs

No single metric tells the full story. See the FRA:LCLA stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

PT Kalbe Farma Tbk Business Description

Address Jalan Let. Jend. Suprapto Kav. 4, Gedung KALBE, Cempaka Putih, P.O. Box 3105, Jakarta, IDN, 10510
PT Kalbe Farma Tbk is engaged in the development, manufacturing, and trading of pharmaceutical products, including human medicines and consumer health products. The company operates four segments: prescription pharmaceuticals, consumer health, Nutritionals, and distribution and logistics. The majority of the company's revenue is derived from the distribution and logistics segments. Its Product and Services are Prescription /Ethicals, Consumer Health, Nutritionals, Distribution & Logistics, Health Services, Medical Devices, and Others.
76GF Score

Get the complete analysis for FRA:LCLA

Tariff Resilience Score is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€0.03
Price
€0.07
GF Value